证券记录 · 已归档季度
MDGL
Madrigal Pharmaceuticals, Inc. · Healthcare · Biotechnology
13被追踪持有人
+1Δ持有人
2.28M持有股份
$753.61M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +8.3% ·
股份流向 +5.9% ·
净新建仓位 +7.7%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 123 | +1 | 10.48M | $5.62B | +9 | −7 |
| Q1 2026 | 124 | +7 | 12.07M | $6.32B | +9 | −3 |
| Q4 2025 | 116 | 0 | 12.47M | $7.26B | +1 | — |
| Q3 2025 | 19 | +1 | 6.80M | $3.12B | +1 | −1 |
| Q2 2025 | 16 | 0 | 6.45M | $1.95B | — | — |
| Q1 2025 | 13 | +1 | 2.28M | $753.61M | +1 | — |
| Q4 2024 | 12 | +2 | 2.15M | $662.73M | +2 | — |
| Q3 2024 | 9 | +1 | 1.41M | $299.66M | +3 | −2 |
| Q2 2024 | 8 | — | 1.43M | $401.79M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 758.51K | -2.9% | $251.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 542.63K | -7.8% | $179.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 542.63K | -7.8% | $179.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 420.88K | +2.5% | $139.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 420.88K | +2.5% | $139.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 191.61K | +860.0% | $63.47M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 99.01K | +315.2% | $32.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Norges Bank ✦ (被动) | 94.00K | -18.3% | $31.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 85.09K | -47.1% | $28.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 65.86K | 新增 | $21.81M | 0.1% | New | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 2.80K | -84.0% | $927,444 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Millennium Management ✦ | 2.51K | +90.8% | $830,394 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 801 | -94.6% | $265,315 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $21.81M | 0.1% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 374 持有人, 23.71M 股份, $12.08B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
Kelley Shannon T
Officer · 664 股 · $341,940
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 29
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据